5G·

FDA allows further marketing for 20 ZYN products

Philip Morris $PM (-0,71%) has permission to market 20 ZYN products (2 strengths per 10 flavors).


The FDA's decision sets the stage for further marketing of Reduced Risk Products.


I hope, however, that the FDA will pay close attention to who they give permission to and that the barriers to market entry will remain high.

attachment
5
2 Commenti

immagine del profilo
" However, the FDA emphasizes that while authorized, these products are not "FDA approved" or safe. The agency will monitor their marketing and use, and may suspend or withdraw authorization if necessary. "

🤣🤣🤣🤣
2
immagine del profilo
@Jo_Wolf is still nicotine 🤷‍♂️
Partecipa alla conversazione